Myeloid cell populations and fibrogenic parameters in bleomycin-and HOCL-induced fibrosis

Experimental Dermatology

Volumn 25, Issue 11, 2016, Pages 887-894

  Raker, Verena K ^a   Kim, Yong Ook ^a   Haub, Jessica ^a   Lorenz, Nadine ^a   Schmidt, Talkea ^a   Stegemann, Agatha ^b   Böhm, Markus ^b   Schuppan, Detlef ^a   Steinbrink, Kerstin ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bleomycin; Dermal fibrosis; Hypochloric acid; Macrophages; Myeloid cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CD11B ANTIGEN; CD19 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLAGEN; COLLAGENASE 3; GLYCOPROTEIN P 15095; HYPOCHLORIC ACID; INORGANIC ACID; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN ALPHA1; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; HYPOCHLOROUS ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; COLLAGEN DEPOSITION; COLLAGEN METABOLISM; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCLERODERMA; SKIN FIBROSIS; SKINFOLD THICKNESS; TOXICITY TESTING; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; FIBROSIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN; SYSTEMIC SCLEROSIS;

ANIMALS; BLEOMYCIN; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HYPOCHLOROUS ACID; MICE, INBRED C57BL; MYELOID CELLS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 85014400742     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.13124     Document Type: Article

References (39)

1. Eckes B, Moinzadeh P, Sengle G, et al. J Mol Med. 2014;92:913–924.
2. Batteux F, Kavian N, Servettaz A. Curr Opin Rheumatol. 2011;23:511–518.
3. Yamamoto T. Br J Dermatol. 2006;155:869–875.
4. Wick G, Backovic A, Rabensteiner E, et al. Trends Immunol. 2010;31:110–119.
5. Higashi-Kuwata N, Makino T, Inoue Y, et al. Exp Dermatol. 2009;18:727–729.
6. Svegliati S, Cancello R, Sambo P, et al. J Biol Chem. 2005;280:36474–36482.
7. Gabrielli A, Svegliati S, Moroncini G, et al. Open Rheumatol J. 2012;6:87–95.
8. Servettaz A, Goulvestre C, Kavian N, et al. J Immunol. 2009;182:5855–5864.
9. Greenblatt MB, Sargent JL, Farina G, et al. Am J Pathol. 2012;180: 1080–1094.
10. Aliprantis AO, Wang J, Fathman JW, et al. Proc Natl Acad Sci USA. 2007;104:2827–2830.
11. Lattouf R, Younes R, Lutomski D, et al. J Histochem Cytochem. 2014;62:751–758.
12. Hadi AM, Mouchaers KTB, Schalij I, et al. Cell Oncol (Dordr). 2011;34:343–354.
13. Stegemann A, Sindrilaru A, Eckes B, et al. Arthritis Rheum. 2013;65:792–804.
14. Asano Y, Ihn H, Kubo M, et al. Rheumatology. 2006;45:303–307.
15. Peng W, Yan J, Wan Y, et al. J Clin Immunol. 2012;32:1409–1414.
16. Andrianifahanana M, Wilkes MC, Gupta SK, et al. FASEB J. 2013;27:4444–4454.
17. Charni Chaabane S, Coomans de Brachène A, Essaghir A, et al. PLoS One. 2014;9:e108656.
18. Invernizzi P, Pasini S, Selmi C, et al. J Autoimmun. 2009;33:12–16.
19. Isolation of skin dendritic cells from mouse and man – Springer [Internet]. In: Naik SH, ed. Humana Press; 2010 [cited March 9, 2015]. http://link.springer.com/protocol/10.1007%2F978-1-60761-421-0_16. Accessed 06 November 2009.
20. Malissen B, Tamoutounour S, Henri S. Nat Rev Immunol. 2014;14:417–428.
21. Tamoutounour S, Guilliams M, Montanana Sanchis F, et al. Immunity. 2013;39:925–938.
22. Arai M, Ikawa Y, Chujo S, et al. J Dermatol Sci. 2013;69:250–258.
23. Kalderén C, Stadler C, Forsgren M, et al. Int Immunopharmacol. 2014;20:66–73.
24. Manne J, Markova M, Siracusa LD, et al. Biochem Res Int. 2013;2013:436053.
25. Wynn TA, Ramalingam TR. Nat Med. 2012;18:1028–1040.
26. Wynn TA, Chawla A, Pollard JW. Nature. 2013;496:445–455.
27. Sedky MM, Fawzy SM, El Baki NA, et al. Skin Res Technol. 2013;19:e78–e84.
28. Bourji K, Meyer A, Chatelus E, et al. Free Radic Biol Med. 2015;87:282–289.
29. Yamamoto T. Eur J Dermatol. 2009;19:14–24.
30. Broen JCA, Dieude P, Vonk MC, et al. J Rheumatol. 2012;39:112–118.
31. Granel B, Chevillard C, Allanore Y, et al. Immunogenetics. 2006;58:693–699.
32. Oh M-H, Oh SY, Yu J, et al. J Immunol. 2011;186:7232–7242.
33. O’Reilly S. BioFactors. 2013;39:593–596.
34. Fernando MR, Reyes JL, Iannuzzi J, et al. PLoS One. 2014;9:e94188.
35. Milano A, Pendergrass SA, Sargent JL, et al. PLoS One. 2008;3:e2696.
36. Fleming JN, Shulman HM, Nash RA, et al. PLoS One. 2009;4:e6203.
37. Pattanaik D, Brown M, Postlethwaite BC, et al. Front Immunol. 2015;6:272.
38. Higashi-Kuwata N, Jinnin M, Makino T, et al. Arthritis Res Ther. 2010;12:R128.
39. Xia M, Sui Z. Expert Opin Ther Pat. 2009;19:295–303.